(JKE) iShares Morningstar Growth - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642871192 • Large Growth

JKE: Large-Cap Stocks, Mid-Cap Stocks, Growth Equities, US Companies

The iShares Morningstar Growth ETF (NYSE ARCA: JKE) is designed to provide exposure to large- and mid-capitalization U.S. equities that exhibit growth characteristics. The fund tracks the Morningstar® US Large-Mid Cap Broad Growth IndexSM, which is built using Morningstars proprietary methodology to identify companies with above-average growth potential. By focusing on growth-oriented stocks, the ETF offers investors a way to tap into companies that are expected to deliver higher-than-average revenue and earnings growth.

The ETF typically invests at least 90% of its assets in securities from the underlying index, which includes both large- and mid-cap U.S. stocks. This means the fund is heavily aligned with the performance of the Morningstar index, ensuring that investors gain exposure to a diversified portfolio of growth-oriented companies. The fund may also invest in depositary receipts, which provide access to foreign securities, though its primary focus remains on U.S. equities.

As a non-diversified fund, JKE can take larger positions in individual securities compared to diversified funds. This approach allows the fund to more closely replicate the weighting of the Morningstar index, which may include significant exposure to top holdings. However, this also means that the funds performance can be more volatile, as it is less spread out across a broader range of companies.

With an AUM of approximately $2.56 billion, JKE is a sizable ETF that offers liquidity and scale. The fund is domiciled in the United States and is listed on the NYSE ARCA, making it easily accessible to U.S. investors. While the fund does not provide details on specific valuation metrics like P/E, P/B, or P/S, its focus on growth stocks means it may trade at higher valuations relative to broader market indices.

For investors and fund managers, JKE provides a targeted way to gain exposure to the growth segment of the U.S. equity market. Its reliance on Morningstars index methodology ensures a systematic approach to selecting growth-oriented companies, which can be appealing to those looking for a rules-based investment strategy. However, as with any growth-focused investment, its important to consider the potential for higher volatility and the cyclicality of growth stocks in different market environments.

Additional Sources for JKE ETF

JKE ETF Overview

Market Cap in USD 2,303m
Category Large Growth
TER 0.04%
IPO / Inception 2004-06-28

JKE ETF Ratings

Growth 5y -15.9%
Fundamental -
Dividend 37.5%
Rel. Strength Industry 1.11
Analysts -
Fair Price Momentum 72.38 USD
Fair Price DCF -

JKE Dividends

Dividend Yield 12m 0.54%
Yield on Cost 5y 0.26%
Annual Growth 5y 22.49%
Payout Consistency 42.0%

JKE Growth Ratios

Growth Correlation 3m -37.6%
Growth Correlation 12m 89.1%
Growth Correlation 5y -24.8%
CAGR 5y -13.22%
CAGR/Max DD 5y -0.16
Sharpe Ratio 12m 1.58
Alpha 0.02
Beta 1.37
Volatility 42.98%
Current Volume 89.8k
Average Volume 20d 78.6k
What is the price of JKE stocks?
As of March 14, 2025, the stock is trading at USD 82.49 with a total of 89,832 shares traded.
Over the past week, the price has changed by -2.16%, over one month by -11.64%, over three months by -11.00% and over the past year by +10.18%.
Is iShares Morningstar Growth a good stock to buy?
Neither. Based on ValueRay Analyses, iShares Morningstar Growth is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -15.87 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JKE as of March 2025 is 72.38. This means that JKE is currently overvalued and has a potential downside of -12.26%.
Is JKE a buy, sell or hold?
iShares Morningstar Growth has no consensus analysts rating.
What are the forecast for JKE stock price target?
According to ValueRays Forecast Model, JKE iShares Morningstar Growth will be worth about 81.7 in March 2026. The stock is currently trading at 82.49. This means that the stock has a potential downside of -0.92%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 81.7 -0.9%